Teva Pharmaceuticals USA, Inc. Expands Voluntary Nationwide Recall of Losartan Potassium to 50 mg and 100 mg Tablets USP, Sold Exclusively to Golden State Medical Supply, Inc. | FDA
Teva's Israeli Plant Receives FDA Stamp of Approval for Migraine Drug Manufacturing | Ctech
FDA Fires Back Over Teva Suit on Restasis 180 Days of Exclusivity | RAPS
Teva Migraine Drug Wins FDA Nod, Bolstering Turnaround Plan - Bloomberg
US FDA nod to Teva for key specialty product to weigh on Sun Pharma | Business Standard News
Teva Develops First FDA-Approved Digitally-Integrated Inhaler
Troubled Teva plant in Hungary faces an FDA crackdown - STAT
Teva and MedinCell Announce FDA Acceptance of New Drug Application for TV-46000/mdc-IRM as a Treatment for Patients with Schizophrenia | Business Wire
Teva secures FDA approval for Ajovy to prevent migraine episodes
Teva Calls on FDA to Make Copaxone a Biologic as Part of March Transition | RAPS
Teva pulls over 2.5M vials of U.S. made drugs after FDA concerns on contamination | Seeking Alpha
FDA approves Teva drug for emergency COVID-19 trials - www.israelhayom.com
Teva Shares Pop as FDA Approves Its Migraine Drug - TheStreet
Teva Finally Wins FDA Approval for Potential Huntington's Blockbuster Austedo | BioSpace
Teva Stops Production At US Plant After FDA Concerns: Report
Teva's pursuit of J&J boosted by FDA acceptance of filing for approval of long-acting schizophrenia drug | FiercePharma
Teva recall: Tainted blood pressure drugs continue to show up in U.S. supply | FiercePharma
Teva Receives FDA Approval for Migraine Autoinjector | Ctech
Teva confirms US FDA warning letter for Hangzhou, China API plant
Teva Pharmaceuticals USA Issues Voluntary Nationwide Recall of all Amlodipine/Valsartan Combination Tablets and Amlodipine/Valsartan/Hydrochlorothiazide Combination Tablets that are Within Expiry | FDA
The Teva Advantage
Teva halts output at U.S. drug plant after FDA flags concerns | Reuters
Jobs with Teva Pharmaceuticals, Inc.
